Antioxidant Breakthrough: A New Era in Multi-Modal Melasma Management, Systematic Review

Melasma is a persistent facial hyperpigmentation disorder driven by a complex interplay of genetics, hormones, and environmental triggers, yet a critical clinical gap exists in understanding how to effectively balance the oxidative stress that promotes inflammation and cellular damage in these patients. Consequently, Rashmi Sarkar and Anjali Sahu from the Department of Dermatology at Lady Hardinge Medical College conducted this systematic review to thoroughly investigate the potential of various exogenous and endogenous antioxidants as safe and effective alternatives or adjuvants in current clinical management protocols.

Therefore, the systematic review utilized a comprehensive search of the PubMed database for English-language peer-reviewed articles published over the last decade until January 31, 2024, focusing on study designs such as Randomized Controlled Trials (RCTs) and observational studies involving human populations while excluding animal models and conference abstracts. The investigators assessed the impact of several key antioxidant interventions on clinical outcomes like the Melasma Area and Severity Index (MASI) score by evaluating thirty specific articles to identify optimal therapeutic combinations that enhance patient well-being.

Key Clinical Findings of the Study Include:

• Optimized Peeling Regimens: Research demonstrated that combining a 20% Trichloroacetic Acid (TCA) peel with a 5% topical Magnesium Ascorbyl Phosphate (MAP) cream resulted in a statistically significant 81.1% reduction in MASI scores compared to only 66.2% for those receiving the peel alone.

• Cysteamine Efficacy: Investigations revealed that 5% cysteamine cream is significantly more effective than the Modified Kligman’s Formula (MKF) in reducing pigmentation, providing a safe and well-tolerated option for patients who need to rotate off hydroquinone(HQ).

• Silymarin Performance: Evidence showed that silymarin cream at concentrations of 0.7% and 1.4% provides clinical results equivalent to 4% hydroquinone but with a notable absence of the significant adverse effects often associated with traditional depigmenting agents.

• Glutathione Synergy: Data highlighted that adding glutathione to microneedling or mesotherapy cocktails significantly accelerates the treatment response and leads to more substantial reductions in the hemi-Modified Melasma Area and Severity Index (hemi-mMASI) scores than standard therapies alone.

• Zinc Sulfate Comparison: Findings established that although 10% topical zinc sulfate reduces melasma severity, its potency is markedly lower than hydroquinone, showing only an 18.6% improvement compared to the 43.5% reduction seen with the standard treatment.

The results suggest that incorporating these antioxidants into routine care can safely enhance efficacy, with data showing that combined approaches, such as using oral lycopene from tomato extract as an adjuvant, significantly boost serum Superoxide Dismutase (SOD) levels while improving skin appearance. These diverse agents demonstrate a clear potential to serve as safe, effective, and sometimes synergistic components of a modern, multi-modal dermatological strategy.

Thus, the study concludes clinicians may find value in adopting these antioxidant therapies as part of a comprehensive management plan to improve patient outcomes and minimize treatment-related side effects.

While the current evidence is encouraging, the lack of statistical significance for certain agents like melatonin and the small sample sizes in some split-face trials indicate a need for larger, long-term prospective studies to fully validate these findings and optimize treatment strategies.

Reference

Sarkar R, Sahu A. Role of antioxidants in melasma: A systematic review. Indian J Dermatol 2025;70:125-34.